BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38275833)

  • 1. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
    Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
    Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study.
    Kozawa E; Nishida Y; Kawai A; Hayakawa K; Setsu N; Kawashima H; Iwata S; Tsuchiya H; Tsukushi S; Takenaka S; Imanishi J; Baba I; Nagano A; Morii T; Shirai T; Shimizu K; Kawano H
    Cancer Sci; 2022 Jul; 113(7):2397-2408. PubMed ID: 35485870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.
    Hompland I; Ferrari S; Bielack S; Palmerini E; Hall KS; Picci P; Hecker-Nolting S; Donati DM; Blattmann C; Bjerkehagen B; Staals E; Kager L; Gambarotti M; Kühne T; Eriksson M; Ferraresi V; Kevric M; Biagini R; Baumhoer D; Brosjø O; Comandone A; Schwarz R; Bertulli R; Kessler T; Hansson L; Apice G; Heydrich BN; Setola E; Flörcken A; Ruggieri P; Krasniqi F; Hofmann-Wackersreuther G; Casali P; Reichardt P; Smeland S
    Eur J Cancer; 2021 Jul; 151():150-158. PubMed ID: 33990016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?
    Kawaguchi S; Sun T; Lin PP; Deavers M; Harun N; Lewis VO
    Clin Orthop Relat Res; 2014 Mar; 472(3):983-9. PubMed ID: 24197392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
    Dierselhuis EF; Goulding KA; Stevens M; Jutte PC
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010778. PubMed ID: 30845364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adjuvant chemotherapy on localized dedifferentiated low-grade osteosarcoma: a systematic review.
    Tsukamoto S; Righi A; Mavrogenis AF; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
    Musculoskelet Surg; 2024 May; ():. PubMed ID: 38709428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.
    Dickey ID; Rose PS; Fuchs B; Wold LE; Okuno SH; Sim FH; Scully SP
    J Bone Joint Surg Am; 2004 Nov; 86(11):2412-8. PubMed ID: 15523011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
    Anract P; Tomeno B; Forest M
    Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation.
    Emori M; Nakahashi N; Takasawa A; Murata K; Murahashi Y; Shimizu J; Tsukahara T; Sugita S; Takada K; Hasegawa T; Osanai M; Iba K
    Hum Cell; 2023 Nov; 36(6):2195-2203. PubMed ID: 37454032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.
    Bui N; Dietz H; Farag S; Hirbe AC; Wagner MJ; Van Tine BA; Ganjoo K; Jones RL; Keedy VL; Davis EJ
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct IDH1/2-associated Methylation Profile and Enrichment of
    Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
    Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis.
    Cranmer LD; Chau B; Mantilla JG; Loggers ET; Pollack SM; Kim TS; Kim EY; Kane GM; Thompson MJ; Harwood JL; Wagner MJ
    Clin Orthop Relat Res; 2022 Apr; 480(4):748-758. PubMed ID: 34648466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
    Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
    Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response.
    Singh A; Thorpe SW; Darrow M; Carr-Ascher JR
    Front Oncol; 2022; 12():991724. PubMed ID: 36465334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and Long-Term Outcome of Surgically Managed High-Grade Extremity Chondrosarcoma.
    Gulbrandsen TR; Skalitzky MK; Russell MD; An Q; Hasan O; Miller BJ
    Iowa Orthop J; 2023; 43(1):71-75. PubMed ID: 37383872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dedifferentiated chondrosarcomas arising in preexisting osteochondromas.
    Staals EL; Bacchini P; Mercuri M; Bertoni F
    J Bone Joint Surg Am; 2007 May; 89(5):987-93. PubMed ID: 17473135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedifferentiated chondrosarcoma of the middle finger arising from a solitary enchondroma: A case report.
    Yonezawa H; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Morinaga S; Asano Y; Saito S; Tome Y; Ikeda H; Nojima T; Tsuchiya H
    World J Clin Cases; 2022 Apr; 10(10):3297-3305. PubMed ID: 35647122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and external validation of nomograms to predict sarcoma-specific death and disease progression after surgical resection of localized high-grade conventional primary central chondrosarcoma and dedifferentiated chondrosarcoma.
    Tsuda Y; Tsoi K; Stevenson JD; Laitinen M; Ferguson PC; Wunder JS; Griffin AM; van de Sande MAJ; van Praag V; Leithner A; Fujiwara T; Yasunaga H; Matsui H; Parry MC; Jeys LM
    Bone Joint J; 2020 Dec; 102-B(12):1752-1759. PubMed ID: 33249892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign looking giant cell component in dedifferentiated chondrosarcoma: benign or malignant? A case report.
    Huang J; Jiang Z; Yang Q; Zhang H
    Int J Surg Pathol; 2013 Feb; 21(1):48-53. PubMed ID: 22736299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
    Xu X; Tang X; Guo W; Yang K; Ren T
    Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.